SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-014845
Filing Date
2019-05-01
Accepted
2019-05-01 16:31:35
Documents
71
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20190331.htm 10-Q 1357788
2 EX-31.1 vtvt-ex311_11.htm EX-31.1 17634
3 EX-31.2 vtvt-ex312_10.htm EX-31.2 17526
4 EX-32.1 vtvt-ex321_7.htm EX-32.1 7262
5 EX-32.2 vtvt-ex322_8.htm EX-32.2 7217
6 GRAPHIC gkn1g2pi5isr000001.jpg GRAPHIC 29851
  Complete submission text file 0001564590-19-014845.txt   5756172

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20190331.xml EX-101.INS 1130651
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20190331.xsd EX-101.SCH 60760
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20190331_cal.xml EX-101.CAL 41681
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20190331_def.xml EX-101.DEF 245476
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20190331_lab.xml EX-101.LAB 417161
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20190331_pre.xml EX-101.PRE 329895
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 19788062
SIC: 2834 Pharmaceutical Preparations